Aclaris Therapeutics - 53 Year Dividend History | ACRS
Historical dividend payout and yield for Aclaris Therapeutics (ACRS) since 1971. The current TTM dividend payout for Aclaris Therapeutics (ACRS) as of May 14, 2024 is $0.00. The current dividend yield for Aclaris Therapeutics as of May 14, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.084B |
$0.031B |
|
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
